MedPath

Acute Kidney Injury in Patients With CoVID-19

Completed
Conditions
Acute Kidney Injury
Covid19
Registration Number
NCT04872764
Lead Sponsor
Uşak University
Brief Summary

We aimed to investigate the effect of Acute Kidney Injury (AKİ) on the prognosis of patients hospitalised for COVID-19.

Detailed Description

The effect of Acute Kidney Injury (AKİ) on the prognosis of patients hospitalised for COVID-19. Patients hospitalised for COVID-19 and acute kidney injury will be enrolled. The duration of hospitalisation, mortality rates will be compared in COVID-19 patients with and without acute kidney injury.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
600
Inclusion Criteria
  • Patients hospitalised with COVID-19.
  • Patients hospitalised with COVID-19 with Acute Kidney Injury
Exclusion Criteria

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
mortality rate6 months

mortality rates of COVID-19 patients with and without Acute Kidney Injury

duration of hospitalisation6 months

time between admission to hospital and discharge for COVID-19 patients with and without Acute Kidney Injury

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Usak University

🇹🇷

Usak, Turkey

Usak University
🇹🇷Usak, Turkey

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.